Identifying clinical characteristics of infantile hemangioma
Clinical Characteristics of Infantile Hemangioma: a Prospective Study
This study is trying to learn more about infantile hemangiomas in young children to improve how they are diagnosed and treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | N/A to 6 Years |
| Sex | All |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Trial ID | NCT03331744 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify the clinical characteristics of infantile hemangioma (IH) in patients at a single center in China. It focuses on understanding the prevalence, risk factors, and clinical features of IH, including cases of infantile hepatic hemangioma (IHH) and ulceration. The study will involve children aged six years and younger diagnosed with IH, gathering data to improve prevention, diagnosis, and treatment strategies for this common benign tumor. The findings will help fill the knowledge gap regarding IH in the Chinese population.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged six years and younger diagnosed with infantile hemangioma.
Not a fit: Patients older than six years or those with congenital hemangioma or previous treatments for hemangioma may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of infantile hemangioma, leading to better outcomes for affected patients.
How similar studies have performed: While there is limited data on similar studies in the Chinese population, previous research has shown success in understanding IH characteristics in other demographics.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≤6 years old * Diagnose of IHs * Consent of both parents (or the person having parental authority in families) Exclusion Criteria: * Congenital hemangioma, kaposiform hemangioendothelioma, or other vascular anomalies * Age\>6 years * Hemangioma has been previous treated with corticosteroids, laser, cryotherapy, or only other treatments * Patients with an inability to participate or to follow the study treatment and assessment plan
Where this trial is running
Chengdu, Sichuan
- West China Hospital of Sichuan University — Chengdu, Sichuan, China (Recruiting)
Study contacts
- Principal investigator: Yi Ji — West China Hospital
- Study coordinator: Yi Ji
- Email: jijiyuanyuan@163.com
- Phone: +86 02885423453
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.